Premium
Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As 2 O 3 )
Author(s) -
Chun Yong-Jin,
Park In-Chul,
Park Myung-Jin,
Woo Sang-Hyeok,
Hong Seok-Il,
Chung Hee Yong,
Kim Tae-Hwan,
Lee Yun-Sil,
Rhee Chang-Hun,
Lee Su-Jae
Publication year - 2002
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/s0014-5793(02)02765-5
Subject(s) - arsenic trioxide , radiosensitivity , cancer research , clonogenic assay , ionizing radiation , in vivo , apoptosis , cancer cell , chemistry , cancer , leukemia , hela , in vitro , medicine , biology , radiation therapy , immunology , irradiation , biochemistry , physics , microbiology and biotechnology , nuclear physics
Arsenic trioxide (As 2 O 3 ) inhibits cell growth and induces apoptosis in certain types of cancer cells including acute promyelocytic leukemia, prostate and ovarian carcinomas, but its effect on response of tumor cells to ionizing radiation has never been explored before. Here we demonstrate that As 2 O 3 can sensitize human cervical cancer cells to ionizing radiation both in vitro and in vivo. As 2 O 3 in combination with ionizing radiation have a synergistic effect in decreasing clonogenic survival and in the regression of established human cervical tumor xenografts. Pretreatment of the cells with As 2 O 3 also synergistically enhanced radiation‐induced apoptosis. Apoptosis of the cells by combined treatment of As 2 O 3 and radiation was associated with reactive oxygen species generation and loss of mitochondrial membrane potential, resulting in the activation of caspase‐9 and caspase‐3. The combined treatment also resulted in an increased G2/M cell cycle distribution at the concentration of As 2 O 3 which did not alter cell cycle when applied alone. These results indicate that As 2 O 3 can synergistically enhance radiosensitivity of human cervix carcinoma cells in vitro and in vivo, suggesting a potential clinical applicability of combination treatment of As 2 O 3 and ionizing radiation in cancer therapies.